跳至主要内容
临床试验/CTRI/2019/10/021592
CTRI/2019/10/021592招募中未知

Clinical Evaluation of Lohasava and Amalaki Churna in the management of Iron Deficiency Anemia (Pandu)

Central Council For Research In Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. (i)Hb 8gm-10gm.%
  • (ii)S.Ferritin <13 µg/L(female) or <30 µg/L(male)
  • (iii)TIBC level >450mcg/dL
  • (iv)S.Iron <60μg/dL for male; <50 for female
  • (v)MCV level <80fL/red cell
  • (vi)RDW >46fL
  • (vii)Reticulocyte count <0.5%
  • (Among these the first 3 are the essential criteria for inclusion)
  • 2. Willing and able to participate for 112 days.

排除标准

  • 1.Iron deficiency likely or definitely due to blood loss from the intestine or other sites.
  • 2.History or evidence of intestinal malabsorption
  • 3.Major co-morbidity such as a serious chronic medical condition unrelated to iron deficiency apparent on history, physical examination or laboratory tests
  • 4.Other causes of anemia (sickle cell disease, thalassemia,other hemolytic anemia, bone marrow failure, etc.) apparent by history, physical examination, and/or laboratory tests
  • 5.Liver enzymes, AST/ALT > 2 x the upper limit;serum creatinine more than the upper limit.
  • 6.Patients on prolonged ( > 6 weeks) medication that may have an influence on the outcome of the study
  • 7.Other medical or social factors at discretion of treating physician

研究者

相似试验